Ranjeeta Sinvhal MD

Dr. Ranjeeta Sinvhal is an Executive Medical Director of Immunology TA, Medical Safety Evaluation at AbbVie. She has extensive experience in both post-marketing and clinical trials in pharmacovigilance for 18 years. She has in-depth global filing experience as a safety lead for both small molecules and biologics. Intimate knowledge of processes and regulations in ICSR, aggregate reporting, and signal detection. Her current knowledge of PV regulations including EU good pharmacovigilance practices. She has Comprehensive and current knowledge of Internal Medicine (current Board certification) and continuing clinical practice. She has experience working with partners (other pharmaceutical companies, CROs) and key external subject matter experts (consultants and regulatory agencies). Comprehensive knowledge of the drug development process and conduct and reporting of post-authorization.